D. E. Shaw & Co., Inc.

Position in EDIT — Editas Medicine, Inc.

CIK 1009207 New York, NY

Back to EDIT Full portfolio

Position in EDIT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,801,415

+$2,526,756 QoQ

Shares Held

1,943,893

+75.2% QoQ

Ownership

1.99%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.36832942965482.ToString("F0")% Shared 0.ToString("F0")% None 0.6316705703451785.ToString("F0")%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Derivatives in EDIT

reported options exposure · as of Jun 30, 2022

CallValue

CallShares

PutValue

$473,200

PutShares

40,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. EDIT ranks #96 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

All Filings in EDIT

Export CSV

34 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,801,415	1,943,893	+75.2%	Shares	Defined	2026-05-15
2025-12-31	$2,274,659	1,109,590	+855.1%	Shares	Defined	2026-02-17
2025-09-30	$403,141	116,179	+5.5%	Shares	Defined	2025-11-14
2025-06-30	$242,248	110,113	-76.0%	Shares	Defined	2025-08-14
2025-03-31	$533,252	459,700	+156.1%	Shares	Defined	2025-05-15
2024-12-31	$227,983	179,515	-2.8%	Shares	Defined	2025-02-14
2024-09-30	$629,877	184,715	-66.5%	Shares	Defined	2024-11-14
2024-06-30	$2,572,482	550,853	-49.4%	Shares	Defined	2024-08-14
2024-03-31	$8,082,160	1,089,240	-8.3%	Shares	Defined	2024-05-15
2023-12-31	$12,030,022	1,187,564	+77.6%	Shares	Defined	2024-02-14
2023-09-30	$5,216,210	668,745	-14.9%	Shares	Defined	2023-11-14
2023-06-30	$6,469,346	786,069	+57.6%	Shares	Defined	2023-08-14
2023-03-31	$3,616,227	498,790	-1.6%	Shares	Defined	2023-05-15
2022-12-31	$4,496,681	506,954	+206.1%	Shares	Defined	2023-02-14
2022-09-30	$2,027,201	165,621	-53.3%	Shares	Defined	2022-11-14
2022-06-30	$4,197,579	354,825	+787.1%	Shares	Defined	2022-08-15
2022-06-30	$473,200	40,000	-82.2%	Put	Defined	2022-08-15
2022-03-31	$4,271,892	224,600	-64.5%	Put	Defined	2022-05-16
2022-03-31	$12,037,967	632,911	+6229.1%	Shares	Defined	2022-05-16
2021-12-31	$265,500	10,000	-97.2%	Call	Defined	2022-02-14
2021-12-31	$9,641,181	363,133	+204.6%	Shares	Defined	2022-02-14
2021-12-31	$3,164,760	119,200	+49.0%	Put	Defined	2022-02-14
2021-09-30	$3,286,400	80,000	+700.0%	Put	Defined	2021-11-15
2021-09-30	$410,800	10,000	-92.4%	Call	Defined	2021-11-15
2021-09-30	$5,412,166	131,747	+64.7%	Shares	Defined	2021-11-15
2021-06-30	$4,531,200	80,000	-46.7%	Call	Defined	2021-08-16
2021-06-30	$8,496,000	150,000	+23.8%	Put	Defined	2021-08-16
2021-06-30	$6,862,785	121,165	+101.9%	Shares	Defined	2021-08-16
2021-03-31	$2,520,000	60,000	-90.0%	Put	Defined	2021-05-17
2021-03-31	$25,233,936	600,808	-57.4%	Shares	Defined	2021-05-17
2020-12-31	$98,791,509	1,409,093	+41.0%	Shares	Defined	2021-02-16
2020-09-30	$28,032,135	999,007	-21.7%	Shares	Defined	2020-11-16
2020-06-30	$37,763,039	1,276,641	+22.4%	Shares	Defined	2020-08-14
2020-03-31	$20,683,661	1,043,049	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.